{"rows":[{"id":6032,"title":"Safety, Efficacy, and Mechanisms of Psilocybin-assisted Acceptance and Commitment Therapy (PACT) in Treating Major Depressive Disorder (MDD) Among Veterans","authors":"VA Office of Research and Development","journal":"ClinicalTrials.gov","publication_date":"2026-10-26","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07895134","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Psychological Flexibility,Clinical Trial,Randomized Controlled Trial,Veterans,Safety","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-10-27 02:22:54","last_checked":"2026-10-27 02:22:54","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07895134","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07895134","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07895134","source_url":"https://clinicaltrials.gov/study/NCT07895134","doi":"","pmid":"","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":6031,"title":"Substantial Treatment-Seeking Interest, Narrow Eligibility: Diagnostic Heterogeneity and External Validity in the PRIDE Psilocybin Trial-Relevance to Precision Psychiatry","authors":"Inserra Antonio, Persico Luca, Rosati Arianna, Fabale Mara, Cavallotto Clara, D’Andrea Giacomo, Zoratto Francesca, Pettorruso Mauro, De Risio Luisa, Ventriglio Antonio, Bellomo Antonello, Nicolò Giuseppe, Martinotti Giovanni","journal":"Behavioral Sciences","publication_date":"2026-10-26","publication_year":2026,"doi":"10.3390/bs16111997","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.3390/bs16111997","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Clinical Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-10-27 02:20:16","last_checked":"2026-10-27 02:20:16","bibtex":null,"source_record_id":"DOI:10.3390/bs16111997","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/bs16111997","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/bs16111997","source_url":"https://doi.org/10.3390/bs16111997","doi":"10.3390/bs16111997","pmid":"","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":6030,"title":"Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression: A Randomized Clinical Trial.","authors":"Feifel D, Seynaeve M, Cubala WJ, Dunbar F, Gründer G, Dueñas Herrero RM, Hindocha C, Liknaitzky P, McGuigan SM, Mehta S, Pierce M, Repantis D, Roberts C, Wiegand F, Conley R","journal":"JAMA","publication_date":"2026-10-26","publication_year":2026,"doi":"10.1001/jama.2026.18380","pubmed_id":"42931733","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42931733/","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-10-27 02:20:04","last_checked":"2026-10-27 02:20:04","bibtex":null,"source_record_id":"PMID:42931733","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42931733/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42931733","source_url":"https://pubmed.ncbi.nlm.nih.gov/42931733/","doi":"10.1001/jama.2026.18380","pmid":"42931733","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":6029,"title":"Sex-related differences in outcomes following psilocybin or escitalopram: a Bayesian secondary analysis","authors":"Frick Aline, Blest-Hopley Grace, Girn Manesh, Erritzoe David, Nutt David, Carhart-Harris Robin","journal":"Psychopharmacology","publication_date":"2026-10-26","publication_year":2026,"doi":"10.1007/s00213-026-07177-7","pubmed_id":"42931904","openalex_id":null,"source_url":"https://doi.org/10.1007/s00213-026-07177-7","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Drug Interactions","study_type":"Randomized Controlled Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-10-27 02:20:04","last_checked":"2026-10-27 02:20:16","bibtex":null,"source_record_id":"PMID:42931904","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1007/s00213-026-07177-7","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42931904","source_url":"https://doi.org/10.1007/s00213-026-07177-7","doi":"10.1007/s00213-026-07177-7","pmid":"42931904","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":6028,"title":"Direct Quantitation of Psilocybin and Psilocin by 1H and 31P qNMR in Wild Psilocybe from Greece","authors":"Dadiotis E, Antonopoulos R, Cheilari A, Kortsinoglou A, Melliou E, Mitsis V, Ioannidis K, Thankappan B, Delgoda R, Gonou-Zagou Z, Magiatis P.","journal":"ACS omega","publication_date":"2026-10-24","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC13689107","substance_tags":"psilocybin,psilocin","topic_tags":"General","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-26 02:20:18","last_checked":"2026-10-26 02:20:18","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC13689107","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC13689107","source_url":"https://europepmc.org/article/PMC/PMC13689107","doi":"","pmid":"","publication_date":"2026-10-24","importer_version":"2.1.3","text_redistributed":false}},{"id":6027,"title":"Psilocybin and Clinical Depression","authors":"Richard Kensinger","journal":null,"publication_date":"2026-10-23","publication_year":2026,"doi":"10.13140/rg.2.2.36134.89921","pubmed_id":null,"openalex_id":"https://openalex.org/W7223284694","source_url":"https://doi.org/10.13140/rg.2.2.36134.89921","substance_tags":"psilocybin","topic_tags":"Depression,Spirituality","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-25 02:20:27","last_checked":"2026-10-27 02:20:21","bibtex":null,"source_record_id":"DOI:10.13140/rg.2.2.36134.89921","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.13140/rg.2.2.36134.89921","source_url":"https://doi.org/10.13140/rg.2.2.36134.89921","doi":"10.13140/rg.2.2.36134.89921","pmid":"","publication_date":"2026-10-23","importer_version":"2.1.3","text_redistributed":false}},{"id":6026,"title":"Sustained antidepressant-like effects of psychedelics through 5-HT2AR-β-arrestin signaling.","authors":"He L, Tang L, Cao D, Duan W, Yu J, Zhang P, Li H, Wang Y, Meng B, Wang H, Zhou Y, Li W, Li X, Liu Z, Zhang L, Cheng J, Wang S.","journal":"Nature neuroscience","publication_date":"2026-10-23","publication_year":2026,"doi":"10.1038/s41593-026-02497-5","pubmed_id":"42919912","openalex_id":null,"source_url":"https://doi.org/10.1038/s41593-026-02497-5","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Animal Study","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-25 02:20:05","last_checked":"2026-10-27 02:20:17","bibtex":null,"source_record_id":"PMID:42919912","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1038/s41593-026-02497-5","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42919912","source_url":"https://doi.org/10.1038/s41593-026-02497-5","doi":"10.1038/s41593-026-02497-5","pmid":"42919912","publication_date":"2026-10-23","importer_version":"2.1.3","text_redistributed":false}},{"id":6025,"title":"Psilocybin for anhedonia in unipolar and bipolar depression: A systematic review of clinical and preclinical evidence.","authors":"Kaczmarek ES, Wong S, Chisamore N, Stern M, Doyle Z, Johnson DE, McIntyre RS, Rosenblat JD.","journal":"Journal of psychiatric research","publication_date":"2026-10-19","publication_year":2026,"doi":"10.1016/j.jpsychires.2026.10.023","pubmed_id":"42906286","openalex_id":null,"source_url":"https://doi.org/10.1016/j.jpsychires.2026.10.023","substance_tags":"psilocybin","topic_tags":"Depression,Aging,Clinical Trial,Systematic Review,Review Article,Animal Study","study_type":"Systematic Review","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-24 01:20:06","last_checked":"2026-10-26 02:20:18","bibtex":null,"source_record_id":"PMID:42906286","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1016/j.jpsychires.2026.10.023","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42906286","source_url":"https://doi.org/10.1016/j.jpsychires.2026.10.023","doi":"10.1016/j.jpsychires.2026.10.023","pmid":"42906286","publication_date":"2026-10-19","importer_version":"2.1.3","text_redistributed":false}},{"id":6024,"title":"Michael Pollan’s Psychedelic Renaissance: Settler Colonial Time and the De-Indigenization of Mazatec Mushroom Medicine","authors":"Paloma Martínez-Cruz","journal":"A Contracorriente: una revista de estudios latinoamericanos","publication_date":"2026-10-19","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":"https://openalex.org/W7223074775","source_url":"https://acontracorriente.chass.ncsu.edu/index.php/index/article/view/2501","substance_tags":"psilocybin","topic_tags":"Wellbeing,Clinical Trial","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-22 01:20:26","last_checked":"2026-10-26 02:20:23","bibtex":null,"source_record_id":"https://acontracorriente.chass.ncsu.edu/index.php/index/article/view/2501","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://acontracorriente.chass.ncsu.edu/index.php/index/article/view/2501","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"https://acontracorriente.chass.ncsu.edu/index.php/index/article/view/2501","source_url":"https://acontracorriente.chass.ncsu.edu/index.php/index/article/view/2501","doi":"","pmid":"","publication_date":"2026-10-19","importer_version":"2.1.3","text_redistributed":false}},{"id":6023,"title":"How Psilocybin Alters Consciousness","authors":"Allison Parshall","journal":"Scientific American","publication_date":"2026-10-20","publication_year":2026,"doi":"10.1038/scientificamerican112026-3edhifzdtvxbibf0qddjfb","pubmed_id":"42899992","openalex_id":"https://openalex.org/W7223054107","source_url":"https://doi.org/10.1038/scientificamerican112026-3edhifzdtvxbibf0qddjfb","substance_tags":"psilocybin","topic_tags":"Pharmacology,Consciousness","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-22 01:20:26","last_checked":"2026-10-27 02:20:21","bibtex":null,"source_record_id":"PMID:42899992","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:42899992","source_url":"https://doi.org/10.1038/scientificamerican112026-3edhifzdtvxbibf0qddjfb","doi":"10.1038/scientificamerican112026-3edhifzdtvxbibf0qddjfb","pmid":"42899992","publication_date":"2026-10-20","importer_version":"2.1.3","text_redistributed":false}},{"id":6022,"title":"Mikrodosiertes Psilocybin im palliativmedizinischen Kontext","authors":"Neuwersch-Sommeregger Stefan","journal":"Schmerz Nachrichten","publication_date":"2026-10-21","publication_year":2026,"doi":"10.1007/s44180-026-00312-y","pubmed_id":null,"openalex_id":"https://openalex.org/W7223143356","source_url":"https://doi.org/10.1007/s44180-026-00312-y","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-10-22 01:20:21","last_checked":"2026-10-27 02:20:21","bibtex":null,"source_record_id":"DOI:10.1007/s44180-026-00312-y","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1007/s44180-026-00312-y","source_url":"https://doi.org/10.1007/s44180-026-00312-y","doi":"10.1007/s44180-026-00312-y","pmid":"","publication_date":"2026-10-21","importer_version":"2.1.3","text_redistributed":false}},{"id":6021,"title":"Psilocybin and Inflammatory and Mitochondrial Stress Markers in Parkinson Disease: A Nonrandomized Clinical Trial.","authors":"Bradley ER, Kelley P, Szigeti B, Nishimi K, Picard M, Sakai K, Fernandes-Osterhold G, Ostrem JL, Tanner CM, Ludwig C, Llerena K, Finley PR, Busby Z, McKernan A, Pantoni MM, Penn AD, Wang ACC, Zuzuarregui JRP, Woolley JD, O'Donovan A.","journal":"JAMA psychiatry","publication_date":"2026-10-21","publication_year":2026,"doi":"10.1001/jamapsychiatry.2026.2733","pubmed_id":"42905733","openalex_id":"https://openalex.org/W7223091331","source_url":"https://doi.org/10.1001/jamapsychiatry.2026.2733","substance_tags":"psilocybin","topic_tags":"Biomarkers,Mitochondrial Function,Clinical Trial,Inflammation","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-22 01:20:21","last_checked":"2026-10-27 02:20:21","bibtex":null,"source_record_id":"PMID:42905733","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1001/jamapsychiatry.2026.2733","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42905733","source_url":"https://doi.org/10.1001/jamapsychiatry.2026.2733","doi":"10.1001/jamapsychiatry.2026.2733","pmid":"42905733","publication_date":"2026-10-21","importer_version":"2.1.3","text_redistributed":false}},{"id":6020,"title":"Connectedness as a mechanism of change in psilocybin-assisted cognitive behavioral therapy for major depressive disorder","authors":"Lorenzo A. Miller, Cordelia Kuiper-Rauch, Keren Chen, NICHOLAS J. JACKSON, David J. Miklowitz, Marc J. Weintraub","journal":"Psychedelics","publication_date":"2026-10-14","publication_year":2026,"doi":"10.1016/j.psyche.2026.100044","pubmed_id":null,"openalex_id":"https://openalex.org/W7221795368","source_url":"https://doi.org/10.1016/j.psyche.2026.100044","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Mystical Experience,Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-21 01:20:18","last_checked":"2026-10-21 01:20:18","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100044","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100044","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.psyche.2026.100044","source_url":"https://doi.org/10.1016/j.psyche.2026.100044","doi":"10.1016/j.psyche.2026.100044","pmid":"","publication_date":"2026-10-14","importer_version":"2.1.3","text_redistributed":false}},{"id":6019,"title":"Biosynthesis of gold nanoparticles using Psilocybe cubensis extracts and their biostimulatory evaluation in Neuro2a cells","authors":"Manuel Vergara, Felipe Galleguillos, José Becerra","journal":"Frontiers in Nanotechnology","publication_date":"2026-10-19","publication_year":2026,"doi":"10.3389/fnano.2026.1939102","pubmed_id":null,"openalex_id":"https://openalex.org/W7222917562","source_url":"https://doi.org/10.3389/fnano.2026.1939102","substance_tags":"psilocybin","topic_tags":"In Vitro Study,Toxicity","study_type":"In Vitro Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-21 01:20:18","last_checked":"2026-10-26 02:20:23","bibtex":null,"source_record_id":"DOI:10.3389/fnano.2026.1939102","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fnano.2026.1939102","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3389/fnano.2026.1939102","source_url":"https://doi.org/10.3389/fnano.2026.1939102","doi":"10.3389/fnano.2026.1939102","pmid":"","publication_date":"2026-10-19","importer_version":"2.1.3","text_redistributed":false}},{"id":6018,"title":"Clinical Evidence on Psilocybin and Its Representation in Media Reporting","authors":"Madden Kim, Flood Breanne, Kashir Imad, Ahmad Rayan, Ali Hiba, Petranker Rotem, MacKillop James, Adili Anthony","journal":"JAMA Network Open","publication_date":"2026-10-20","publication_year":2026,"doi":"10.1001/jamanetworkopen.2026.38843","pubmed_id":"42900476","openalex_id":"https://openalex.org/W7223031286","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.38843","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Headache / Migraine,Aging,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events","study_type":"Systematic Review","source_name":"Crossref","publication_status":"published","date_added":"2026-10-21 01:20:14","last_checked":"2026-10-27 02:20:21","bibtex":null,"source_record_id":"PMID:42900476","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1001/jamanetworkopen.2026.38843","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42900476","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.38843","doi":"10.1001/jamanetworkopen.2026.38843","pmid":"42900476","publication_date":"2026-10-20","importer_version":"2.1.3","text_redistributed":false}},{"id":6017,"title":"From Altered States to Fundamental Peace: Taxonomies of Consciousness, Psychedelics and Hypnosis Through the Lens of the Yoga Vāsiṣṭha","authors":"Luis Miguel Gallardo","journal":null,"publication_date":"2026-10-18","publication_year":2026,"doi":"10.68220/whf.2026.007","pubmed_id":null,"openalex_id":"https://openalex.org/W7222864490","source_url":"https://doi.org/10.68220/whf.2026.007","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Default Mode Network,Consciousness,Emotional Processing,Mystical Experience,Meta-Analysis,Review Article,Treatment-Resistant Depression","study_type":"Meta-Analysis","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-20 01:20:21","last_checked":"2026-10-25 02:20:27","bibtex":null,"source_record_id":"DOI:10.68220/whf.2026.007","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.68220/whf.2026.007","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.68220/whf.2026.007","source_url":"https://doi.org/10.68220/whf.2026.007","doi":"10.68220/whf.2026.007","pmid":"","publication_date":"2026-10-18","importer_version":"2.1.3","text_redistributed":false}},{"id":6016,"title":"Psilocybin in Treatment-Resistant Depression: Weighing Rapid Antidepressant Effects Against Uncertain Durability","authors":"Szarpak Lukasz, Pruc Michal, Jablonska-Moczulo Dorota, Niewiadomska Iwona, Rybczynski Bernard, Cubała Wiesław J.","journal":"Therapeutics","publication_date":"2026-10-19","publication_year":2026,"doi":"10.3390/therapeutics3040021","pubmed_id":null,"openalex_id":"https://openalex.org/W7222918595","source_url":"https://doi.org/10.3390/therapeutics3040021","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Meta-Analysis,Review Article,Treatment-Resistant Depression,Safety","study_type":"Meta-Analysis","source_name":"Crossref","publication_status":"published","date_added":"2026-10-20 01:20:16","last_checked":"2026-10-26 02:20:23","bibtex":null,"source_record_id":"DOI:10.3390/therapeutics3040021","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/therapeutics3040021","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/therapeutics3040021","source_url":"https://doi.org/10.3390/therapeutics3040021","doi":"10.3390/therapeutics3040021","pmid":"","publication_date":"2026-10-19","importer_version":"2.1.3","text_redistributed":false}},{"id":6015,"title":"Mechanistic Evaluation of Psilocybin in Neurodegenerative Disorders: Relevance of 5-HT2A Receptors and Downstream Pathways.","authors":"Chaudhary S, Dhankhar S, Saini M, Singh TG, Chauhan S, Kumar V.","journal":"CNS & neurological disorders drug targets","publication_date":"2026-10-14","publication_year":2026,"doi":"10.2174/0118715273491538261009064612","pubmed_id":"42895147","openalex_id":"https://openalex.org/W7222979533","source_url":"https://doi.org/10.2174/0118715273491538261009064612","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,OCD,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Randomized Controlled Trial,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Inflammation","study_type":"Randomized Controlled Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-20 01:20:06","last_checked":"2026-10-21 01:20:19","bibtex":null,"source_record_id":"PMID:42895147","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.2174/0118715273491538261009064612","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42895147","source_url":"https://doi.org/10.2174/0118715273491538261009064612","doi":"10.2174/0118715273491538261009064612","pmid":"42895147","publication_date":"2026-10-14","importer_version":"2.1.3","text_redistributed":false}},{"id":6014,"title":"The Hidden Therapeutic Bridge: Exploring Psilocybin's Role in Depression, Inflammation, and Pain - A Narrative Review.","authors":"Vazquez-Barreto M, Ugarte-Rocha M, Flores Vargas A, García Núñez YA, Hahn D, Coffeen U.","journal":"Current neuropharmacology","publication_date":"2026-10-14","publication_year":2026,"doi":"10.2174/011570159x513731260923101459","pubmed_id":"42895152","openalex_id":null,"source_url":"https://doi.org/10.2174/011570159x513731260923101459","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Chronic Pain,Mechanism of Action,Default Mode Network,Mystical Experience,Review Article,Inflammation","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-20 01:20:06","last_checked":"2026-10-21 01:20:15","bibtex":null,"source_record_id":"PMID:42895152","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.2174/011570159x513731260923101459","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42895152","source_url":"https://doi.org/10.2174/011570159x513731260923101459","doi":"10.2174/011570159x513731260923101459","pmid":"42895152","publication_date":"2026-10-14","importer_version":"2.1.3","text_redistributed":false}},{"id":6013,"title":"Investigation of the pharmacological and circuit basis for psychedelic drug effects on interval timing in mice.","authors":"Klein LM, Kopelman J, Sharp RF, Powell SB, Geyer MA, Young JW, Halberstadt AL.","journal":"Psychopharmacology","publication_date":"2026-10-19","publication_year":2026,"doi":"10.1007/s00213-026-07181-x","pubmed_id":"42894023","openalex_id":null,"source_url":"https://doi.org/10.1007/s00213-026-07181-x","substance_tags":"psilocybin,psilocin","topic_tags":"Receptor Pharmacology,Animal Study","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-20 01:20:06","last_checked":"2026-10-26 02:20:18","bibtex":null,"source_record_id":"PMID:42894023","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1007/s00213-026-07181-x","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42894023","source_url":"https://doi.org/10.1007/s00213-026-07181-x","doi":"10.1007/s00213-026-07181-x","pmid":"42894023","publication_date":"2026-10-19","importer_version":"2.1.3","text_redistributed":false}}],"total":5127,"page":1,"per_page":20,"pages":257,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}